Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...